CHAPTER 1. Industry Overview of Interventional Cardiology Devices Market
1.1. Definition and Scope
1.1.1. Definition of Interventional Cardiology Devices
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Interventional Cardiology Devices Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Interventional Cardiology Devices Market By Product
1.2.3. Interventional Cardiology Devices Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Interventional Cardiology Devices Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Interventional Cardiology Devices Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Interventional Cardiology Devices Market By Product
5.1. Introduction
5.2. Interventional Cardiology Devices Revenue By Product
5.2.1. Interventional Cardiology Devices Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Angioplasty Balloons
5.2.2.1. Angioplasty Balloons Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Angioplasty Catheters
5.2.3.1. Angioplasty Catheters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Angioplasty Stents
5.2.4.1. Angioplasty Stents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Hemodynamic Flow Alteration Devices
5.2.5.1. Hemodynamic Flow Alteration Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Endovascular Aneurysm Repair Stent Grafts
5.2.6.1. Endovascular Aneurysm Repair Stent GraftsMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Plaque Modification Devices
5.2.7.1. Plaque Modification DevicesMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.8. Inferior Vena Cava (IVC) Filters
5.2.8.1. Inferior Vena Cava (IVC) FiltersMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.9. Accessories
5.2.9.1. AccessoriesMarket Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. North America Interventional Cardiology Devices Market By Country
6.1. North America Interventional Cardiology Devices Market Overview
6.2. U.S.
6.2.1. U.S. Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
6.3. Canada
6.3.1. Canada Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
6.4. North America PEST Analysis
CHAPTER 7. Europe Interventional Cardiology Devices Market By Country
7.1. Europe Interventional Cardiology Devices Market Overview
7.2. U.K.
7.2.1. U.K. Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
7.3. Germany
7.3.1. Germany Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
7.4. France
7.4.1. France Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
7.5. Spain
7.5.1. Spain Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
7.6. Rest of Europe
7.6.1. Rest of Europe Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Interventional Cardiology Devices Market By Country
8.1. Asia Pacific Interventional Cardiology Devices Market Overview
8.2. China
8.2.1. China Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3. Japan
8.3.1. Japan Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.4. India
8.4.1. India Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.5. Australia
8.5.1. Australia Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.6. South Korea
8.6.1. South Korea Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Interventional Cardiology Devices Market By Country
9.1. Latin America Interventional Cardiology Devices Market Overview
9.2. Brazil
9.2.1. Brazil Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3. Mexico
9.3.1. Mexico Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4. Rest of Latin America
9.4.1. Rest of Latin America Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Interventional Cardiology Devices Market By Country
10.1. Middle East & Africa Interventional Cardiology Devices Market Overview
10.2. GCC
10.2.1. GCC Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3. South Africa
10.3.1. South Africa Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Interventional Cardiology Devices Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis OfInterventional Cardiology Devices Market
11.1. Interventional Cardiology Devices Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Interventional Cardiology Devices Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Medtronic PLC
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Billion), 2022
12.1.3.2. Medtronic PLC 2022 Interventional Cardiology Devices Business Regional Distribution
12.1.4. Product/Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. Abbott Laboratories
12.3. Boston Scientific Corporation
12.4. Johnson & Johnson (through its subsidiary, Cordis Corporation)
12.5. Terumo Corporation
12.6. B. Braun Melsungen AG
12.7. Edwards Lifesciences Corporation
12.8. Cardinal Health, Inc.
12.9. Cook Medical (a subsidiary of Cook Group)
12.10. Stryker Corporation
The market size of interventional cardiology devices was USD 16.7 Billion in 2022.
The CAGR of interventional cardiology devices is 8.2% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson (through its subsidiary, Cordis Corporation), Terumo Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Cardinal Health, Inc., Cook Medical (a subsidiary of Cook Group), and Stryker Corporation.
Asia-Pacific held the dominating position in interventional cardiology devices industry during the analysis period of 2023 to 2032.
North America region exhibited fastest growing CAGR for market of interventional cardiology devices during the analysis period of 2023 to 2032.
The current trends and dynamics in the interventional cardiology devices industry include rising prevalence of cardiovascular diseases globally, increasing demand for minimally invasive procedures, and technological advancements and innovations in interventional cardiology devices.
The interventional cardiology stents product held the maximum share of the interventional cardiology devices industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date